T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Microchip Technology
MCHP
$34.9B
| $137M | 0.02% |
2,824,213
+296,379
| +12% | +$14.3M |
|
502
MP Materials
MP
$11.2B
| $136M | 0.02% |
5,589,268
-948,243
| -15% | -$23.1M |
|
|
SARO
503
StandardAero, Inc.
SARO
$9.08B
| $136M | 0.02% |
5,115,657
-1,177,869
| -19% | -$31.4M |
|
504
Axon Enterprise
AXON
$59.4B
| $136M | 0.02% |
258,471
-21,016
| -8% | -$11.1M |
|
505
Global X Copper Miners ETF NEW
COPX
$2.24B
| $135M | 0.02% |
3,462,776
-26,584
| -0.8% | -$1.04M |
|
506
Entergy
ETR
$40.3B
| $135M | 0.02% |
1,576,403
-461,601
| -23% | -$39.5M |
|
507
ZTO Express
ZTO
$15.2B
| $134M | 0.02% |
6,772,015
+149,522
| +2% | +$2.97M |
|
508
Vaxcyte
PCVX
$4.18B
| $134M | 0.02% |
3,542,007
-424,949
| -11% | -$16M |
|
509
VF Corp
VFC
$5.8B
| $132M | 0.02% |
8,534,676
-5,148,154
| -38% | -$79.9M |
|
510
Credicorp
BAP
$21.1B
| $132M | 0.02% |
708,582
-48,689
| -6% | -$9.06M |
|
511
Confluent
CFLT
$6.63B
| $129M | 0.02% |
5,510,743
+654,827
| +13% | +$15.3M |
|
512
T. Rowe Price Small-Mid Cap ETF
TMSL
$910M
| $127M | 0.02% |
+4,169,160
| New | +$127M |
|
513
TPG
TPG
$9.05B
| $127M | 0.02% |
2,669,590
+416,520
| +18% | +$19.8M |
|
514
Summit Therapeutics
SMMT
$14.1B
| $127M | 0.02% |
6,557,804
-123
| -0% | -$2.37K |
|
515
Amcor
AMCR
$19.1B
| $123M | 0.02% |
12,643,651
+151,026
| +1% | +$1.46M |
|
|
DFS
516
DELISTED
Discover Financial Services
DFS
| $123M | 0.02% |
717,833
+192,447
| +37% | +$32.9M |
|
517
Kimco Realty
KIM
$15.2B
| $122M | 0.02% |
5,733,286
-573,123
| -9% | -$12.2M |
|
518
Arcellx
ACLX
$4.23B
| $121M | 0.01% |
1,839,624
-281,698
| -13% | -$18.5M |
|
|
VRNA
519
Verona Pharma
VRNA
$9.21B
| $118M | 0.01% |
1,866,280
+32,748
| +2% | +$2.08M |
|
520
Ryanair
RYAAY
$31.1B
| $118M | 0.01% |
+2,786,653
| New | +$118M |
|
521
Aramark
ARMK
$10.1B
| $117M | 0.01% |
3,397,158
-707,173
| -17% | -$24.4M |
|
522
Ultragenyx Pharmaceutical
RARE
$2.92B
| $117M | 0.01% |
3,218,942
+706,519
| +28% | +$25.6M |
|
523
Robinhood
HOOD
$102B
| $116M | 0.01% |
2,796,075
-2,389,150
| -46% | -$99.4M |
|
524
Paychex
PAYX
$48.6B
| $116M | 0.01% |
753,450
+17,522
| +2% | +$2.7M |
|
525
MoonLake Immunotherapeutics
MLTX
$3.34B
| $116M | 0.01% |
2,973,830
-369,813
| -11% | -$14.4M |
|